Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

S9031-S9126-S9333-S9500-A, Examination of the Prognostic Significance of AML-Specific and Age-Associated Genes in AML Patients

NCT00899171 is registered in ClinicalTrials.gov with SWOG Cancer Research Network as lead sponsor.

NCT NCT00899171
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00899171 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
S9031-S9126-S9333-S9500-A, Examination of the Prognostic Significance of AML-Specific and Age-Associated Genes in AML Patients
Lead sponsor
SWOG Cancer Research Network
Phase
Observational
Overall status
Completed
Start date
November 30, 2008
Completion date
September 30, 2012
Enrollment
251 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia